ImmuPharma plcLSE: IMM

Notification of Full Year Results

· Issued by ImmuPharma plc

On 6ix: 6ix.com/news/notification-of-full-year-results-14

Watch ImmuPharma's latest callImmupharma (LSE:IMM) — Corporate Update · Replay · Mar 20Read the transcript of Immupharma (LSE:IMM) — Corporate Update
RNS Number : 7012F
Immupharma PLC
22 May 2017
 

                                                                                                                        22 MAY 2017

ImmuPharma PLC

("ImmuPharma" or the "Company")

NOTIFICATION OF FULL YEAR RESULTS

Date: 1 June 2017

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, confirms that it will be announcing its full year results for the year ended 31 December 2016 on Thursday  1 June 2017.

-Ends-

For further information please contact:

ImmuPharma plc (www.immupharma.org)

+ 44 (0) 20 7152 4080

Tim McCarthy, Chairman

Lisa Baderoon, Head of Investor Relations

Twitter: @immupharma

+ 44 (0) 7721 413496

Northland Capital Partners Limited (Joint Broker)

Patrick Claridge, David Hignell, Corporate Finance

Rob Rees, Corporate Broking

+44 (0)20 3861 6625

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORKMGMKZLVGNZM

ImmuPharma plc on 6ix

Story so far

Earlier from ImmuPharma

Later from ImmuPharma

All ImmuPharma news releases